Molecular Pathogenesis and Complications Associated with Keratosis Follicularis: A Clinical Review
Main Article Content
Keywords
Darier's Disease, Keratosis Follicularis, neuropsychiatric, diabetes, heart disease, basal cell carcinoma, retinoid, dermabrasion, YAG laser
Abstract
Keratosis follicularis or Darier's disease (DD) is a rare autosomal dominant disorder characterized by the appearance of multiple scaly papules affecting seborrheic areas. It is a multisystem disorder that occurs in the first or second decade of life, and extends beyond cutaneous involvement. It has been reported to be associated with various basal cell carcinoma (BCC) and other skin cancers, nail changes, ocular/mucosal manifestations and neuropsychiatric disorders. Additionally, individuals with DD have a greater risk of being diagnosed with Type 1 Diabetes Mellitus as well as disease-specific risk of heart failure. The goal of this review is to explore the molecular pathogenesis of keratosis follicularis, and to investigate the extent and severity of various complications associated with this condition. Furthermore, dermatologic practice recommendations will be reviewed for the management of DD.
References
2. Schmieder SJ, Rosario-Collazo JA. Keratosis Follicularis. StatPearls. StatPearls Publishing
Copyright © 2020, StatPearls Publishing LLC.; 2020.
3. Suryawanshi H, Dhobley A, Sharma A, Kumar P. Darier disease: A rare genodermatosis. J Oral Maxillofac Pathol. May-Aug 2017;21(2):321. doi:10.4103/jomfp.JOMFP_170_16
4. Oster-Schmidt C. The treatment of Darier's disease with topical tazarotene. Br J Dermatol. Sep 1999;141(3):603-4. doi:10.1046/j.1365-2133.1999.03089.x
5. McKenna KE, Walsh MY, Burrows D. Treatment of unilateral Darier's disease with topical isotretinoin. Clin Exp Dermatol. Sep 1999;24(5):425-7. doi:10.1046/j.1365-2230.1999.00519.x
6. English JC, 3rd, Browne J, Halbach DP. Effective treatment of localized Darier's disease with adapalene 0.1% gel. Cutis. Apr 1999;63(4):227-30.
7. Beier C, Kaufmann R. Efficacy of erbium:YAG laser ablation in Darier disease and Hailey-Hailey disease. Arch Dermatol. Apr 1999;135(4):423-7. doi:10.1001/archderm.135.4.423
8. Heo EP, Park SH, Yoon TJ, Kim TH. Induction of Darier's disease by repeated irradiation by ultraviolet B; protection by sunscreen and topical ascorbic acid. J Dermatol. Jul 2002;29(7):455-8. doi:10.1111/j.1346-8138.2002.tb00306.x
9. Soroush V, Gurevitch AW. Darier's disease associated with multiple café-au-lait macules. Cutis. 1997/04// 1997;59(4):193-195.
10. Cederlöf M, Bergen SE, Långström N, et al. The association between Darier disease, bipolar disorder, and schizophrenia revisited: a population-based family study. Bipolar Disord. May 2015;17(3):340-4. doi:10.1111/bdi.12257
11. Cederlöf M, Curman P, Ahanian T, et al. Darier disease is associated with type 1 diabetes: Findings from a population-based cohort study. J Am Acad Dermatol. Dec 2019;81(6):1425-1426. doi:10.1016/j.jaad.2019.05.087
12. Savignac M, Edir A, Simon M, Hovnanian A. Darier disease : a disease model of impaired calcium homeostasis in the skin. Biochim Biophys Acta. May 2011;1813(5):1111-7. doi:10.1016/j.bbamcr.2010.12.006
13. Chemaly ER, Troncone L, Lebeche D. SERCA control of cell death and survival. Cell Calcium. Jan 2018;69:46-61. doi:10.1016/j.ceca.2017.07.001
14. Verboomen H, Wuytack F, De Smedt H, Himpens B, Casteels R. Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban. Biochem J. Sep 1 1992;286 ( Pt 2)(Pt 2):591-5. doi:10.1042/bj2860591
15. Robia SL, Young HS. Skin cells prefer a slower calcium pump. J Biol Chem. Mar 16 2018;293(11):3890-3891. doi:10.1074/jbc.H118.002088
16. Savignac M, Simon M, Edir A, Guibbal L, Hovnanian A. SERCA2 dysfunction in Darier disease causes endoplasmic reticulum stress and impaired cell-to-cell adhesion strength: rescue by Miglustat. J Invest Dermatol. Jul 2014;134(7):1961-1970. doi:10.1038/jid.2014.8
17. Pani B, Cornatzer E, Cornatzer W, et al. Up-regulation of transient receptor potential canonical 1 (TRPC1) following sarco(endo)plasmic reticulum Ca2+ ATPase 2 gene silencing promotes cell survival: a potential role for TRPC1 in Darier's disease. Mol Biol Cell. Oct 2006;17(10):4446-58. doi:10.1091/mbc.e06-03-0251
18. Pasmatzi E, Badavanis G, Monastirli A, Tsambaos D. Reduced expression of the antiapoptotic proteins of Bcl-2 gene family in the lesional epidermis of patients with Darier's disease. Journal of cutaneous pathology. 04/01 2007;34:234-8. doi:10.1111/j.1600-0560.2006.00600.x
19. Korosec B, Glavac D, Rott T, Ravnik-Glavac M. Alterations in the ATP2A2 gene in correlation with colon and lung cancer. Cancer Genet Cytogenet. Dec 2006;171(2):105-11. doi:10.1016/j.cancergencyto.2006.06.016
20. Kosann MK. Keratosis follicularis. Dermatol Online J. Oct 2003;9(4):35.
21. Blackman HJ, Rodrigues MM, Peck GL. Corneal epithelial lesions in keratosis follicularis (Darier's disease).
Ophthalmology. Sep 1980;87(9):931-43. doi:10.1016/s0161-6420(80)35142-7
22. Mohamed KN. Darier's disease and corneal opacity. Dermatologica. 1991;182(3):205. doi:10.1159/000247787
23. Roy FH. Ocular Syndromes and Systemic Diseases. 4th ed. MedRounds Publications, Inc.; 2008:396.
24. Radia M, Gilhooley MJ, Panos C, Claoué C. Recurrent presumed herpes simplex keratitis and episcleritis in keratosis
follicularis (Darier's disease). BMJ Case Rep. Jul 16 2015;2015doi:10.1136/bcr-2015-210772
25. Russell DJ, Dutton JJ, Fowler AM. Darier Disease Mimicking Basal Cell Carcinoma of the Eyelid. Ophthalmic Plastic & Reconstructive Surgery. 2009;25(2):144-146. doi:10.1097/IOP.0b013e31819aadad
26. Itin P, Büchner SA, Gloor B. Darier's disease and retinitis pigmentosa; is there a pathogenetic relationship? Br J Dermatol. Sep 1988;119(3):397-402. doi:10.1111/j.1365-2133.1988.tb03235.x
27. Wright JC. Darier's disease. Am J Ophthalmol. Jan 1963;55:134-6. doi:10.1016/0002-9394(63)91659-3
28. Gordon-Smith K, Jones LA, Burge SM, Munro CS, Tavadia S, Craddock N. The neuropsychiatric phenotype in Darier disease. Br J Dermatol. Sep 2010;163(3):515-22. doi:10.1111/j.1365-2133.2010.09834.x
29. Karagas NE, Venkatachalam K. Roles for the Endoplasmic Reticulum in Regulation of Neuronal Calcium Homeostasis. Cells. Oct 10 2019;8(10)doi:10.3390/cells8101232
30. Nakamura T, Kazuno AA, Nakajima K, Kusumi I, Tsuboi T, Kato T. Loss of function mutations in ATP2A2 and psychoses: A case report and literature survey. Psychiatry Clin Neurosci. Aug 2016;70(8):342-50. doi:10.1111/pcn.12395
31. Ahanian T, Curman P, Leong IUS, et al. Metabolic phenotype in Darier disease: a cross-sectional clinical study. Diabetol Metab Syndr. 2020;12:12. doi:10.1186/s13098-020-0520-0
32. Tong X, Kono T, Anderson-Baucum EK, et al. SERCA2 Deficiency Impairs Pancreatic β-Cell Function in Response to Diet-Induced Obesity. Diabetes. Oct 2016;65(10):3039-52. doi:10.2337/db16-0084
33. Cardozo AK, Ortis F, Storling J, et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes. Feb 2005;54(2):452-61. doi:10.2337/diabetes.54.2.452
34. Bachar-Wikstrom E, Curman P, Ahanian T, et al. Darier disease is associated with heart failure: a cross-sectional case-control and population based study. Sci Rep. Apr 2020;10(1):6886. doi:10.1038/s41598-020-63832-9
35. Prasad V, Lorenz JN, Lasko VM, et al. SERCA2 Haploinsufficiency in a Mouse Model of Darier Disease Causes a Selective Predisposition to Heart Failure. Biomed Res Int. 2015;2015:251598. doi:10.1155/2015/2515
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.